Meet the companies that raised the top 10 Dutch funding rounds in Q1 2025; 6 are hiring right now

As Q1 2025 comes to a close, it’s clear that Dutch startups are off to a strong start this year.

According to the fifth edition of the State of Dutch Tech report by Techleap, the Dutch tech companies raised €3.1B in venture capital over the past year, a 47 per cent increase compared to the previous year.

With major funding rounds closing across various industries, it’s an exciting time for innovation in the Netherlands.

Some of these startups aren’t just making waves—they’re also hiring fresh talent to sustain their momentum.

Today, we present a list of the top 10 Dutch funding rounds in Q1 2025. Some of them are hiring, too. Check it out below.

Mews

HQ: Amsterdam

Fund raised in Q1, 2025: €70.6M

CEO: Matt Welle

Hiring: Yes| Apply here

Mews has developed Mews Hospitality Cloud to streamline operations for modern hoteliers, transform the guest experience, and create more profitable businesses. 

The Dutch company’s clients include BWH Hotels, Strawberry, The Social Hub, and Airelles Collection. The company claims to have over 5,500 customers across more than 85 countries.

Leyden Labs

HQ: Leiden

Fund raised in Q1, 2025: €68M

Founder/s: Jaap Goudsmit, Koenraad Wiedhaup, and Ronald Brus

Hiring: Yes| Apply here

Leyden Labs works to free people from the threat of respiratory viruses. The company utilises its platform to target commonalities of viral families to protect against many viruses simultaneously, as opposed to vaccines that typically protect against a specific virus variant. 

The Dutch company’s platform is built on two concepts: broad protection against known viruses, new variants, and newly emerging viruses, and protection at the gate, i.e., in the mucosa (e.g,. in the nose and throat).

Alesta Therapeutics

HQ: Leiden

Fund raised in Q1, 2025: €65M

CEO: Ilan Ganot

Hiring: No

Aesta Therapeutics is a biotechnology company developing transformative small-molecule therapies for rare diseases.

The Dutch company focuses on creating novel oral treatments for underserved conditions. Its lead asset, ALE1, targets hypophosphatasia (HPP), while ALE2 is aimed at treating Charcot-Marie-Tooth (CMT) disease.

Piano

HQ: Amsterdam

Fund raised in Q1, 2025: €111M

Founder/s: Trevor Kaufman

Hiring: Yes| Apply here

Piano.io is a digital experience platform that helps media businesses optimise user engagement and drive revenue.

Its Digital Experience Cloud offers AI-driven recommendations, automation, and personalised journeys to boost conversions for publishers, broadcasters, and content creators. 

The Dutch company operates on a subscription-based model, providing continuous updates and white-labeled solutions for integration.

With open APIs and easy integrations, Piano.io enables businesses to enhance customer interactions efficiently while maximising subscriptions, conversions, and analytics.

The company secured a total financing of $120M (approximately €111M), which includes a $75M (approximately €70M) senior secured term loan facility, led by Runway Growth Capital LLC. 

Additionally, the round features a $45M  (approximately €41.7M) in a Series D investment led by Updata Partners, a Washington, D.C.-based growth equity firm focused on technology.

Vivici

HQ: Delft

Fund raised in Q1, 2025: €32M 

CEO:  Stephan van Sint Fiet

Hiring: No

Vivici is a B2B ingredients company pioneering the development of superior dairy proteins through precision fermentation.

Backed by nutrition, health, and beauty multinational dsm-firmenich and dairy multinational Fonterra, Vivici uses precision fermentation to create dairy protein.

This method blends traditional fermentation with modern biotechnology to produce proteins without involving animals. Vivitein BLG, an isolated whey protein (beta-lactoglobulin), is the first ingredient to be launched under the company’s ViviteinTM protein platform.

Quantware

HQ: Delft

Fund raised in Q1, 2025: €20M 

Founder/s: Alessandro Bruno and Matthijs Rijlaarsdam

Hiring: Yes| Apply here

QuantWare develops quantum hardware and VIO large quantum processors (QPUs) scaling technology. The Dutch company supports quantum computing systems in 20 countries across four continents. 

VIO enables scaling for any qubit design and provides a pathway toward systems with more than 1 million qubits. The technology is available in fully packaged QPUs and through Foundry and Packaging Services.

QuantWare provides VIO through its own designed quantum processors and offers the technology to third-party customers via Foundry and Packaging Services. The company supplies quantum computing technology to customers in 20 countries.

AheadComputing

HQ: Amsterdam

Fund raised in Q1, 2025: €20M

Founder/s: Debbie Marr, Jonathan Pearce, Mark Dechene, and Srikanth Srinivasan

Hiring: No

AheadComputing is a design company that creates and licenses high-performance microprocessor cores. The Dutch company focuses on advancing compute performance with innovative RISC-V processors.

Their solutions cater to various industries, including cloud computing, AI, and edge applications, offering high efficiency and scalability.

Thorizon

HQ: Amsterdam

Fund raised in Q1, 2025: €20M

Founder/s: Sander de Groot and Lucas Pool

Hiring: Yes| Apply here

Thorizon is on a mission to develop a reactor based on molten salt. The Thorizon One is a modular molten salt reactor that transforms nuclear waste into carbon-free energy. Its core consists of multiple fully enclosed ‘cartridges,’ which can be replaced to incorporate innovations. 

Through this, the company has managed to reduce the amount of long-lived radioactive waste and generate 250MW of clean energy in one go.

Workwize

HQ: Amsterdam

Fund raised in Q1, 2025: €12.6M

Founder/s: Michiel Meyer, Victor Dik, Sebastiaan Scholten, and Dirk Kranendijk

Hiring: Yes|Apply here

Workwize simplifies IT hardware management for globally distributed teams, automating procurement, deployment, retrieval, and disposal. 

The platform reduces IT hardware administrative time per employee from hours to minutes, offering zero-touch, end-to-end lifecycle management supported by a global vendor network.

Sirius Medical

HQ: Eindhoven

Fund raised in Q1, 2025: €10M

CEO: Bram Schermers

Hiring: No

Sirius Medical aims to improve care for cancer patients by delivering solutions that enable the precise and efficient removal of tumours. 

The company’s Pintuition technology provides surgeons real-time distance and directional navigational guidance to locate tumours accurately. 

The Sirius Pintuition surgical navigation platform enables simple, best-in-class wire-free localisation for breast-conserving surgery in any hospital.